SEMA4C and breast carcinoma: Notably, soluble Sema4C can be released from the cell surface due to proteolytic cleavage by matrix metalloproteinases (MMPs), and it was proposed as promising serum marker for the early diagnosis and the assessment of metastasis risk in breast cancer 26.